Total Payments
$13,238
2024 Payments
$1,796
Companies
27
Transactions
327
Medicare Patients
12,161
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$13,122 (99.1%)
Education$116.69 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,122 | 325 | 99.1% |
| Education | $116.69 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $5,658 | 64 | $0 (2022) |
| Abbott Laboratories | $2,177 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,864 | 129 | $0 (2024) |
| Medtronic, Inc. | $1,020 | 20 | $0 (2024) |
| Davol Inc. | $266.01 | 2 | $0 (2022) |
| Amgen Inc. | $232.33 | 8 | $0 (2022) |
| Acutus Medical, Inc. | $210.16 | 2 | $0 (2020) |
| Kiniksa Pharmaceuticals International, plc | $208.44 | 9 | $0 (2024) |
| Boston Scientific Corporation | $186.13 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $158.08 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,796 | 55 | Novartis Pharmaceuticals Corporation ($524.38) |
| 2023 | $1,998 | 77 | Novartis Pharmaceuticals Corporation ($495.07) |
| 2022 | $2,054 | 46 | BIOTRONIK INC. ($704.09) |
| 2021 | $385.65 | 11 | BIOTRONIK INC. ($333.56) |
| 2020 | $694.27 | 11 | BIOTRONIK INC. ($281.31) |
| 2019 | $1,148 | 17 | BIOTRONIK INC. ($832.96) |
| 2018 | $2,680 | 53 | BIOTRONIK INC. ($1,877) |
| 2017 | $2,483 | 57 | BIOTRONIK INC. ($1,629) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $138.13 | General |
| Category: EndoVenous Therapies | ||||||
| 11/12/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: EndoVenous Therapies | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.90 | General |
| Category: Cardiovascular | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $72.71 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $144.82 | General |
| Category: EndoVenous Therapies | ||||||
| 09/27/2024 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $71.16 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Not Applicable | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 08/26/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $144.92 | General |
| Category: EndoVenous Therapies | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: EndoVenous Therapies | ||||||
| 08/12/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiovascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 5,006 | 8,346 | $6.5M | $1.7M |
| 2022 | 29 | 2,532 | 4,205 | $2.1M | $533,826 |
| 2021 | 27 | 2,450 | 4,430 | $1.6M | $453,912 |
| 2020 | 28 | 2,173 | 3,858 | $1.3M | $331,121 |
Total Patients
12,161
Total Services
20,839
Medicare Billing
$3.0M
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 452 | 453 | $3.4M | $821,674 | 24.5% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 453 | 463 | $725,492 | $275,630 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 599 | 1,273 | $420,090 | $110,208 | 26.2% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 25 | 25 | $399,525 | $83,250 | 20.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 461 | 1,840 | $297,206 | $79,314 | 26.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 435 | 456 | $317,376 | $66,098 | 20.8% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 425 | 426 | $268,233 | $58,239 | 21.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 258 | 258 | $130,290 | $29,005 | 22.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 30 | 30 | $61,860 | $18,682 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 242 | 282 | $62,604 | $18,281 | 29.2% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 87 | 90 | $70,920 | $17,142 | 24.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 779 | 1,575 | $81,900 | $16,188 | 19.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 118 | $52,628 | $16,017 | 30.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 93 | 94 | $56,964 | $13,440 | 23.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 59 | 62 | $38,440 | $9,024 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $31,115 | $7,793 | 25.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 30 | 30 | $29,370 | $5,771 | 19.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 12 | 12 | $20,076 | $4,663 | 23.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 14 | 43 | $15,996 | $3,959 | 24.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 41 | 199 | $16,318 | $3,811 | 23.4% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 31 | 107 | $12,305 | $2,779 | 22.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 51 | 122 | $12,810 | $2,618 | 20.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 14 | $8,750 | $1,889 | 21.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 51 | 97 | $7,663 | $1,512 | 19.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,642 | $1,112 | 24.0% |
About Dr. Christopher Nguyen, M.D
Dr. Christopher Nguyen, M.D is a Internal Medicine healthcare provider based in Shenandoah, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003825035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Nguyen, M.D has received a total of $13,238 in payments from pharmaceutical and medical device companies, with $1,796 received in 2024. These payments were reported across 327 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($13,122).
As a Medicare-enrolled provider, Nguyen has provided services to 12,161 Medicare beneficiaries, totaling 20,839 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Shenandoah, TX
- Active Since 08/07/2006
- Last Updated 07/12/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003825035
Products in Payments
- ENTRESTO (Drug) $1,071
- VENASEAL (Device) $970.45
- LEQVIO (Drug) $793.30
- CONFIRM RX (Device) $572.43
- Edora 8 DR-T (Device) $475.47
- Mitra Clip system (Device) $279.58
- PROCLAIM (Device) $277.12
- Phasix Mesh (Device) $266.01
- Arcalyst (Drug) $208.44
- Repatha (Biological) $205.17
- Connectivity and Remote care (Device) $186.98
- ELIQUIS (Drug) $179.54
- BIOMONITOR (Device) $176.06
- Merlin Connectivity and Remote (Device) $161.92
- Rivacor (Device) $151.85
- EDWARDS INTUITY Elite valve system (Device) $137.43
- GALLANT (Device) $134.91
- WATCHMAN FLX (Device) $125.55
- XARELTO (Drug) $124.97
- OPSUMIT (Drug) $120.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shenandoah
George Manoukian, M.d, M.D
Internal Medicine — Payments: $252,502
Internal Medicine $252,502
Dr. Rajesh Venkataraman
Internal Medicine — Payments: $226,580
Internal Medicine $226,580
Paul Cunningham, M.d, M.D
Internal Medicine — Payments: $29,344
Internal Medicine $29,344
Dustin Agan, Md, MD
Internal Medicine — Payments: $28,308
Internal Medicine $28,308
Thimos Paschalis, M.d, M.D
Internal Medicine — Payments: $25,701
Internal Medicine $25,701
Andrew Jackson, Md, MD
Internal Medicine — Payments: $18,799
Internal Medicine $18,799